Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Widespread protests have broken out across the United States in response to the police killings of George Floyd, Breonna Taylor and many other black Americans at the hands of police. Demonstrations have also erupted in the UK, Australia, France and several other countries in solidarity with the Black Lives Matter movement and in protest at these countries’ own domestic cases of institutional racism.

The fact that these protests are happening in the middle of a pandemic raises certain issues regarding the spread of the virus, but also they highlight deep inequalities that exist due to structural racism and its effects on people’s health.

It is no coincidence that the people who are most at risk of dying due to institutional racism are also those who are most at risk of COVID-19.

Read the full article on The Conversation website, written by Lakshmi Manoharan, Medical Epidemiologist in Centre for Tropical Medicine & Global Health (Nuffield Department of Medicine)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.